Discern Report is the fastest growing America First news aggregator in the nation.
Source: U.S. Navy photo by Mass Communication Specialist 2nd Class Erwin Jacob Miciano New York’s Department of Health issued a memo this week to health care providers and facilities in the state warning that there is a severe shortage of Covid-19 treatments.
In order to be eligible to receive oral antivirals or monoclonal antibody treatment products, patients need to meet five conditions. The first four are not controversial—there are age and weight requirements, having a mild or moderate case of Covid-19, and able to begin treatment within five days of symptoms. The fifth criterion, however, is more controversial. In addition to meeting the other requirements, patients must also “have a medical condition or other factors that increase their risk for severe illness.”
The memo goes on to state, “Non-white race or Hispanic/Latino ethnicity should be considered a risk factor, as longstanding systemic health and social inequities have contributed to an increased risk of severe illness and death from Covid-19.”
So while white patients can certainly get the treatment, they must have another condition that elevates their risk of severe illness. NY State Department of Health warns they don’t have enough Paxlovid or Monoclonal Antibody Treatment and white people need not apply. https://t.co/shbMWDomLJ […]
Read the whole story at townhall.com
Covid variant BA.5 is spreading. It appears milder but much more contagious and evades natural immunity. Best to boost your immune system with new Z-Dtox and Z-Stack nutraceuticals from our dear friend, the late Dr. Vladimir Zelenko.